Cargando…

The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting

BACKGROUND: Clinical outcomes of novel coronavirus 2019 disease (COVID‐19) in onco‐hematological patients are unknown. When compared to non‐immunocompromised patients, onco‐hematological patients seem to have higher mortality rates. AIMS: We describe the characteristics and outcomes of a consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Condom, Maria, Mussetti, Alberto, Maluquer, Clara, Parody, Rocío, González‐Barca, Eva, Arnan, Montserrat, Albasanz‐Puig, Adaia, Pomares, Helena, Salas, Maria Queralt, Carro, Itziar, Peña, Marta, Clapes, Victòria, Baca Cano, Cristina, Oliveira Ramos, Ana Carla, Sanz‐Linares, Gabriela, Moreno‐González, Gabriel, Mercadal, Santiago, Boqué, Concepcion, Gudiol, Carlota, Domingo‐Domènech, Eva, Sureda, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994963/ https://www.ncbi.nlm.nih.gov/pubmed/33656801 http://dx.doi.org/10.1002/cnr2.1358

Ejemplares similares

Handling the COVID-19 pandemic in the oncological setting
por: Mussetti, Alberto, et al.
Publicado: (2020)

Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience
por: Salas, Maria Queralt, et al.
Publicado: (2022)

Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance
por: Gudiol, Carlota, et al.
Publicado: (2021)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study
por: Sanz-Linares, Gabriela, et al.
Publicado: (2022)

Liquid biopsy for disease monitoring after anti‐CD19 chimeric antigen receptor T cell in diffuse large B‐cell lymphoma
por: Maluquer, Clara, et al.
Publicado: (2020)

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic
por: Mussetti, Alberto, et al.
Publicado: (2020)

Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
por: Mussetti, Alberto, et al.
Publicado: (2021)

Is Post-Transplant Cyclophosphamide the New Methotrexate?
por: Mussetti, Alberto, et al.
Publicado: (2021)

A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial
por: Moreno-González, G., et al.
Publicado: (2021)

Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)
por: Laporte-Amargos, J., et al.
Publicado: (2020)

Low-Dose PET/CT and Full-Dose Contrast-Enhanced CT at the Initial Staging of Localized Diffuse Large B-Cell Lymphomas
por: Sabaté-Llobera, Aida, et al.
Publicado: (2016)

Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease
por: Sánchez-Ortega, Isabel, et al.
Publicado: (2016)

A fresh look at polymicrobial bloodstream infection in cancer patients
por: Royo-Cebrecos, Cristina, et al.
Publicado: (2017)

Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation
por: Domingo-Domènech, Eva, et al.
Publicado: (2020)

Allogeneic Hematopoietic Transplantation for Multiple Myeloma in the New Drugs Era: A Platform to Cure
por: Mussetti, Alberto, et al.
Publicado: (2020)

Clinical Characteristics and Risk of Relapse for Patients with Stage I–II Diffuse Large B-cell Lymphoma Treated in First Line with Immunochemotherapy
por: Mercadal, S, et al.
Publicado: (2013)

Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era
por: Mussetti, Alberto, et al.
Publicado: (2022)

Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy
por: Velasco, Roser, et al.
Publicado: (2021)

CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?
por: Velasco, Roser, et al.
Publicado: (2023)

Increase in Bloodstream Infection Due to Vancomycin-Susceptible Enterococcus faecium in Cancer Patients: Risk Factors, Molecular Epidemiology and Outcomes
por: Gudiol, Carlota, et al.
Publicado: (2013)

COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain
por: Peremiquel-Trillas, Paula, et al.
Publicado: (2022)

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
por: Bergas, Alba, et al.
Publicado: (2022)

PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
por: Lopez Pereira, P., et al.
Publicado: (2022)

From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis
por: Nozal, Vanesa, et al.
Publicado: (2021)

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival
por: Mussetti, Alberto, et al.
Publicado: (2020)

Targeting prohibitins induces apoptosis in acute myeloid leukemia cells
por: Pomares, Helena, et al.
Publicado: (2016)

Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study
por: Albasanz-Puig, Adaia, et al.
Publicado: (2019)

Role of Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the CART Era
por: González Barca, Eva
Publicado: (2022)

Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis
por: Garcia-Vidal, Carolina, et al.
Publicado: (2015)

Current Challenges in the Management of Infective Endocarditis
por: Cuervo, Guillermo, et al.
Publicado: (2021)

Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia
por: Albasanz-Puig, Adaia, et al.
Publicado: (2022)

Increasing Gram-Negative Catheter-Related Bloodstream Infection in Cancer Patients
por: Laporte-Amargos, Julia, et al.
Publicado: (2023)

Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy
por: Martín-Martín, Lourdes, et al.
Publicado: (2016)

Bloodstream Infections in Patients With Solid Tumors: Epidemiology, Antibiotic Therapy, and Outcomes in 528 Episodes in a Single Cancer Center
por: Marín, Mar, et al.
Publicado: (2014)

Comparison of different automatic methods for the delineation of the total metabolic tumor volume in I–II stage Hodgkin Lymphoma
por: Martín-Saladich, Queralt, et al.
Publicado: (2020)

Eating out of Home: Influence on Nutrition, Health, and Policies: A Scoping Review
por: Gesteiro, Eva, et al.
Publicado: (2022)

Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive
por: Gudiol, Carlota, et al.
Publicado: (2022)

Twenty-Year Secular Trends in Infective Endocarditis in a Teaching Hospital
por: Cuervo, Guillermo, et al.
Publicado: (2018)

Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors
por: Gallego, Miguel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iebdqbjqmk7r2qqrvk1jhl97t6